Increased Constitutive Interferon-β Levels and Altered CD4 T Cell Homeostasis Induced by Expression of a Viral Glycoprotein

IF 3.7 3区 医学 Q2 IMMUNOLOGY
Hanspeter Pircher, Oliver S. Thomas, Anne S. Haefke, Annette Oxenius, Thomas Boehm
{"title":"Increased Constitutive Interferon-β Levels and Altered CD4 T Cell Homeostasis Induced by Expression of a Viral Glycoprotein","authors":"Hanspeter Pircher,&nbsp;Oliver S. Thomas,&nbsp;Anne S. Haefke,&nbsp;Annette Oxenius,&nbsp;Thomas Boehm","doi":"10.1002/eji.70188","DOIUrl":null,"url":null,"abstract":"<p>Besides the strong Type I interferon (IFN-I) response induced by infections, IFN-I is also produced constitutively at lower levels. Constitutive IFN-I production is regulated by resident microbiota and is essential for induction of efficient immune responses. Here, we demonstrate in transgenic (tg) mice that expression of a single viral envelope gene, the glycoprotein (GP) of lymphocytic choriomeningitis virus (LCMV), increased constitutive IFN-β levels and induced numerous IFN-stimulated genes (ISGs). In addition, self-antigen-driven CD44<sup>high</sup>CD62L<sup>low</sup> memory-phenotype CD4 T cells and regulatory CD4 T cell populations were enlarged in these LCMV GP-tg mice; by contrast, the fraction of bona fide antigen-specific memory CD4 T cells remained unchanged. Our study demonstrates that expression of a single viral envelope gene increased constitutive IFN-β levels, induced upregulation of ISGs, and altered CD4 T cell homeostasis. Our results further suggest that a hitherto undefined signaling pathway capable of inducing IFN-β expression can detect LCMV GP at the protein or transcript level.</p>","PeriodicalId":165,"journal":{"name":"European Journal of Immunology","volume":"56 4","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2026-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.70188","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Immunology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/eji.70188","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Besides the strong Type I interferon (IFN-I) response induced by infections, IFN-I is also produced constitutively at lower levels. Constitutive IFN-I production is regulated by resident microbiota and is essential for induction of efficient immune responses. Here, we demonstrate in transgenic (tg) mice that expression of a single viral envelope gene, the glycoprotein (GP) of lymphocytic choriomeningitis virus (LCMV), increased constitutive IFN-β levels and induced numerous IFN-stimulated genes (ISGs). In addition, self-antigen-driven CD44highCD62Llow memory-phenotype CD4 T cells and regulatory CD4 T cell populations were enlarged in these LCMV GP-tg mice; by contrast, the fraction of bona fide antigen-specific memory CD4 T cells remained unchanged. Our study demonstrates that expression of a single viral envelope gene increased constitutive IFN-β levels, induced upregulation of ISGs, and altered CD4 T cell homeostasis. Our results further suggest that a hitherto undefined signaling pathway capable of inducing IFN-β expression can detect LCMV GP at the protein or transcript level.

Abstract Image

一种病毒糖蛋白表达诱导的组成型干扰素-β水平升高和CD4 T细胞稳态改变
除了感染诱导的强I型干扰素(IFN-I)应答外,IFN-I也在较低水平下组成性地产生。组成型IFN-I的产生受常驻微生物群的调节,对诱导有效的免疫反应至关重要。在这里,我们在转基因(tg)小鼠中证明了单个病毒包膜基因,淋巴细胞性脉络丛脑膜炎病毒(LCMV)的糖蛋白(GP)的表达,增加了组成型IFN-β水平,并诱导了许多IFN刺激基因(ISGs)。此外,自身抗原驱动的cd44highcd62low记忆型CD4 T细胞和调节性CD4 T细胞群在LCMV GP-tg小鼠中增加;相比之下,真正抗原特异性记忆CD4 T细胞的比例保持不变。我们的研究表明,单个病毒包膜基因的表达增加了构成性IFN-β水平,诱导isg上调,并改变了CD4 T细胞的稳态。我们的研究结果进一步表明,迄今为止尚未确定的能够诱导IFN-β表达的信号通路可以在蛋白或转录物水平上检测LCMV GP。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.30
自引率
3.70%
发文量
224
审稿时长
2 months
期刊介绍: The European Journal of Immunology (EJI) is an official journal of EFIS. Established in 1971, EJI continues to serve the needs of the global immunology community covering basic, translational and clinical research, ranging from adaptive and innate immunity through to vaccines and immunotherapy, cancer, autoimmunity, allergy and more. Mechanistic insights and thought-provoking immunological findings are of interest, as are studies using the latest omics technologies. We offer fast track review for competitive situations, including recently scooped papers, format free submission, transparent and fair peer review and more as detailed in our policies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书